BCL2 and polycystic ovary syndrome: To validate the expression of NDDGs in PCOS, we first tested the expression of NDDGs using the validation set GSE84958, which showed significant differences in BCL2 (Fold change (FC) = 1.5), PYGM (FC = 1.87) and IL33 (FC = 1.76) (Figure S4).